This analysis examines the potential impacts of a provision in the House reconciliation bill that proposes reducing the federal matching rate for the Affordable Care Act (ACA) Medicaid expansion population from 90% to 80% for states that either provide health coverage or financial assistance to purchase health coverage to individuals who are not lawfully residing…
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) is considering certain changes to the current meningococcal vaccination schedule. Here’s why the ACIP should scrap that proposal. The post Protecting Our Future: Why We Must Guard Against Gaps in Public Health appeared first on MedCity News.
“An Arm and a Leg” updates a popular episode from 2019 — a story about giving. In 1980, a young father named Denny Buehler was battling leukemia and needed to travel from Ohio to Seattle for treatment. To raise money for the trip, his friends and family organized a softball tournament. Denny passed away a…
Vesalius Therapeutics’ AI-based technology finds novel targets and intervention points for subgroups of patients within a common disease. A small molecule that Vesalius has been developing for a novel Parkinson’s disease target is now headed to GSK, which has licensed global rights. The post GSK Wagers $80M on a Tech Platform and Parkinson’s Drug from…
Investors hammered the company’s shares on the “prudent” guidance, even though CEO Eric Evans said he doesn’t see the slowdown being a long-term trend
C3HIE will be adding more than 20 hospitals to its network and expanding the HIE’s reach into rural healthcare communities in Texas
As more Americans feel the squeeze on their household budgets, paying for healthcare is a growing concern. A 2024 survey by Pew Research Center found that the number of Americans who rate their personal finances positively has dropped from 50% to 40% over the last three years, with nearly 60% of Americans now saying their…
TrampolineAI launched out of Redesign Health to help health plans with their contact centers. The post Startup Launches To Offer Payers an AI-Powered Contact Center Platform appeared first on MedCity News.
Beam Therapeutics’ first clinical data in the rare disease alpha-1 antitrypsin deficiency “set a bar for efficacy in the space,” according to one analyst. But the ongoing market slide poses challenges for biotech companies aiming to raise money by selling stock. The post Beam Base Editor’s Early Data in Rare Liver Disease Tee Up $500M…
Liz Cinqueonce, the nonprofit organization’s CEO, discusses the creation of a payer-provider pipeline to ease data sharing to enable value-based care